XT
STOK icon

XTX Topco’s Stoke Therapeutics STOK Stock Holding History

XTX Topco’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6M Buy
79,613
+71,559
+888% +$2.3M 0.03% 858
2026
Q1 		$262K Buy
+8,054
New +$264K ﹤0.01% 2600
2025
Q2 		– Sell
-40,181
Closed -$267K – 3130
2025
Q1 		$267K Buy
+40,181
New +$375K 0.01% 1490
2024
Q2 		– Sell
-16,308
Closed -$220K – 2444
2024
Q1 		$220K Buy
+16,308
New +$98.8K 0.03% 1095
2022
Q4 		– Sell
-11,135
Closed -$143K – 1490
2022
Q3 		$143K Buy
+11,135
New +$177K 0.04% 876
2021
Q3 		– Sell
-6,422
Closed -$216K – 1043
2021
Q2 		$216K Buy
+6,422
New +$227K 0.07% 529

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's STOK Position: Q2 2026 in Review

XTX Topco increased its Stoke Therapeutics (STOK) stake by 888% in Q2 2026, buying an estimated $2.3M and bringing the position to 79,613 shares worth $2.6M. The position accounts for 0.03% of the portfolio, ranked #858.

XTX Topco first reported a position in STOK in Q2 2021 and has held it in 6 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • XTX Topco held 79,613 shares of Stoke Therapeutics worth $2.6M as of Q2 2026.
  • XTX Topco bought 71,559 Stoke Therapeutics shares in Q2 2026, an estimated $2.3M.
  • Stoke Therapeutics made up 0.03% of XTX Topco's portfolio in Q2 2026, its #858 holding.
  • XTX Topco first reported a position in Stoke Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.